Healthcare | January 05, 2023
Viatris acquires Oyster Point Pharma and Famy Life Sciences
Acquisitions have the potential to add at least $1 billion in sales by 2028
Acquisitions have the potential to add at least $1 billion in sales by 2028
BDRs journey for the treatment of Prostate Cancer started with Abiratarone Acetate, then Leuprolide Acetate followed by Enzalutamide and, then Degarelix and Triptorelin.
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
To create leading company developing medicines targeting metalloenzymes
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
Having a healthy gut is key as it permits the body to build a stronger immune system
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
Subscribe To Our Newsletter & Stay Updated
